Successful approach to treatment of helicobacter bilis infection in x-linked agammaglobulinemia

Journal of Clinical Immunology

Volumn 32, Issue 6, 2012, Pages 1404-1408

  Turvey, Stuart E ^a,g   Leo, Sara H ^a   Boos, Annette ^b   Deans, Gregory D ^a   Prendiville, Julie ^a   Crawford, Richard I ^a   Senger, Christof ^a   Conley, Mary Ellen ^c   Tilley, Peter ^d   Junker, Anne ^a   Janz, Loretta ^e   Azana, Robert ^e   Hoang, Linda ^a   Morton, Tracy L ^f  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^d BC Children's and Women's Hospitals   (Canada)

^e BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^f Department of Family Practice   (Canada)

^g BC CHILDREN S HOSPITAL   (Canada)

Author keywords

Helicobacter bilis; infection; X linked agammaglobulinemia

Indexed keywords

AZITHROMYCIN; ERTAPENEM; LEVOFLOXACIN; PREDNISONE; RNA 16S; ANTIINFECTIVE AGENT; BETA LACTAM; OFLOXACIN;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL SKIN DISEASE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CASE REPORT; CELLULITIS; CLINICAL FEATURE; ERYTHEMA NODOSUM; HELICOBACTER BILIS; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; LEG SWELLING; MALE; NONHUMAN; OTITIS MEDIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SKIN BIOPSY; SKIN EDEMA; SUBCUTANEOUS NODULE; X LINKED AGAMMAGLOBULINEMIA; ADULT; AGAMMAGLOBULINEMIA; CHRONIC DISEASE; DRUG EFFECT; GENETICS; HELICOBACTER; PATHOGENICITY; PATHOLOGY; PHYLOGENY; REVIEW; TREATMENT OUTCOME; X CHROMOSOME LINKED DISORDER;

ADOLESCENT; ADULT; AGAMMAGLOBULINEMIA; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BETA-LACTAMS; CHRONIC DISEASE; GENETIC DISEASES, X-LINKED; HELICOBACTER; HELICOBACTER INFECTIONS; HUMANS; MALE; OFLOXACIN; PHYLOGENY; TREATMENT OUTCOME;

EID: 84878336178     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-012-9750-8     Document Type: Article

References (20)

1. Conley ME, Dobbs AK, Farmer DM, Kilic S, Paris K, Grigoriadou S, et al. Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol. 2009;27:199-227.
2. Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore). 2006;85(4):193-202.
3. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150(9):1881-4.
4. Smet A, Flahou B, Mukhopadhya I, Ducatelle R, Pasmans F, Haesebrouck F, et al. The other helicobacters. Helicobacter. 2011;16 Suppl 1:70-5.
5. Weir S, Cuccherini B, Whitney AM, Ray ML, MacGregor JP, Steigerwalt A, et al. Recurrent bacteremia caused by a "Flexispira"-like organism in a patient with X-linked (Bruton's) agammaglobulinemia. J Clin Microbiol. 1999;37(8):2439-45.
6. Cuccherini B, Chua K, Gill V, Weir S, Wray B, Stewart D, et al. Bacteremia and skin/bone infections in two patients with X-linked agammaglobulinemia caused by an unusual organism related to Flexispira/ Helicobacter species. Clin Immunol. 2000;97(2):121-9.
7. Gerrard J, Alfredson D, Smith I. Recurrent bacteremia and multifocal lower limb cellulitis due to Helicobacter-like organisms in a patient with X-linked hypogammaglobulinemia. Clin Infect Dis. 2001;33(10):E116-8.
8. Murray PR, Jain A, Uzel G, Ranken R, Ivy C, Blyn LB, et al. Pyoderma gangrenosum-like ulcer in a patient with X-linked agammaglobulinemia: identification of Helicobacter bilis by mass spectrometry analysis. Arch Dermatol. 2010;146(5):523-6.
9. Han S, Schindel C, Genitsariotis R, Marker-Hermann E, Bhakdi S, Maeurer MJ. Identification of a unique Helicobacter species by 16S rRNA gene analysis in an abdominal abscess from a patient with X-linked hypogammaglobulinemia. J Clin Microbiol. 2000;38(7):2740-2.
10. Simons E, Spacek LA, Lederman HM, Winkelstein JA. Helicobacter cinaedi bacteremia presenting as macules in an afebrile patient with X-linked agammaglobulinemia. Infection. 2004;32(6):367-8.
11. Funato M, Kaneko H, Ohkusu K, Sasai H, Kubota K, Ohnishi H, et al. Refractory chronic pleurisy caused by Helicobacter equorum-like bacterium in a patient with X-linked agammaglobulinemia. J Clin Microbiol. 2011;49(9):3432-5.
12. Schwarze-Zander C, Becker S, Wenzel J, Rockstroh JK, Spengler U, Yassin AF. Bacteremia caused by a novel helicobacter species in a 28-year-old man with X-linked agammaglobulinemia. J Clin Microbiol. 2010;48(12):4672-6.
13. Sharp SE. Chronic skin lesions from a patient with Bruton's X-linked agammaglobulinemia. J Clin Microbiol. 2011;49(2):483. 770.
14. van den Bruele T, Mourad-Baars PE, Claas EC, van der Plas RN, Kuijper EJ, Bredius RG. Campylobacter jejuni bacteremia and Helicobacter pylori in a patient with X-linked agammaglobulinemia. Eur J Clin Microbiol Infect Dis. 2010;29(11):1315-9.
15. Jirapongsananuruk O, Wanotayan K, Phongsamart W, Chokephaibulkit K, Visitsunthorn N, Luangwedchakarn V, et al. Recurrent Campylobacter lari bacteremia in X-linked agammaglobulinemia: a case report and review. Asian Pac J Allergy Immunol. 2006;24(2-3):171-4.
16. Arai A, Kitano A, Sawabe E, Kanegane H, Miyawaki T, Miura O. Relapsing Campylobacter coli bacteremia with reactive arthritis in a patient with X-linked agammaglobulinemia. Intern Med. 2007;46(9):605-9.
17. Autenrieth IB, Schuster V, Ewald J, Harmsen D, Kreth HW. An unusual case of refractory Campylobacter jejuni infection in a patient with X-linked agammaglobulinemia: successful combined therapy with maternal plasma and ciprofloxacin. Clin Infect Dis. 1996;23(3):526-31.
18. Desar IM, van Deuren M, Sprong T, Jansen JB, Namavar F, Vandenbroucke-Grauls CM, et al. Serum bactericidal activity against Helicobacter pylori in patients with hypogammaglobulinaemia. Clin Exp Immunol. 2009;156(3):434-9.
19. Marron TU, Martinez-Gallo M, Yu JE, Cunningham-Rundles C. Toll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines. J Allergy Clin Immunol. 2012;129(1):184-90 e1-4.
20. Mangla A, Khare A, Vineeth V, Panday NN, Mukhopadhyay A, Ravindran B, et al. Pleiotropic consequences of Bruton tyrosine kinase deficiency in myeloid lineages lead to poor inflammatory responses. Blood. 2004;104(4):1191-7.